Apis Capital Advisors, LLC Opiant Pharmaceuticals, Inc. Transaction History

Apis Capital Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$9.38 - $20.29 $93,800 - $202,900	10,000 Added 4.9%	214,000 $4.34 Million
Q3 2022 Nov 14, 2022	BUY	$9.52 - $13.48 $76,160 - $107,840	8,000 Added 4.08%	204,000 $2.19 Million
Q2 2022 Aug 12, 2022	BUY	$10.12 - $23.32 $850,079 - $1.96 Million	84,000 Added 75.0%	196,000 $2.35 Million
Q1 2022 May 13, 2022	BUY	$19.54 - $33.59 $39,080 - $67,180	2,000 Added 1.82%	112,000 $2.4 Million
Q4 2021 Feb 14, 2022	BUY	$22.51 - $36.79 $180,080 - $294,320	8,000 Added 7.84%	110,000 $3.7 Million
Q3 2021 Nov 12, 2021	BUY	$13.28 - $25.79 $239,040 - $464,220	18,000 Added 21.43%	102,000 $2.63 Million
Q2 2021 Aug 16, 2021	BUY	$10.5 - $14.19 $42,000 - $56,760	4,000 Added 5.0%	84,000 $1.12 Million
Q1 2021 May 14, 2021	BUY	$8.2 - $14.49 $131,200 - $231,840	16,000 Added 25.0%	80,000 $850,000
Q4 2020 Feb 16, 2021	BUY	$6.87 - $8.88 $322,890 - $417,360	47,000 Added 276.47%	64,000 $514,000
Q3 2019 Nov 14, 2019	BUY	$11.26 - $16.48 $191,420 - $280,160	17,000 New	17,000 $256,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Apis Capital Advisors, LLC with notifications on news.